Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non–Small-cell Lung Cancer: A Systematic Review
2019 ◽
Vol 213
(5)
◽
pp. 1059-1072
◽
2014 ◽
Vol 45
(2)
◽
pp. 509-515
◽
2020 ◽
Vol 45
(4)
◽
pp. 743-754
◽
2015 ◽
Vol 33
(5)
◽
pp. 1148-1150
◽
2019 ◽
Vol 42
(11)
◽
pp. 599-606
◽
Keyword(s):